Kirby Institute, The University of New South Wales, Sydney, New South Wales, Australia ; National Drug Alcohol Research Centre, The University of New South Wales, Sydney, New South Wales, Australia.
PLoS One. 2013 Sep 16;8(9):e73181. doi: 10.1371/journal.pone.0073181. eCollection 2013.
This study aims to describe the trends in and determinants of six month mortality and loss to follow up (LTFU) during 2005-2009 in 13 outpatient clinics in Vietnam.
Data were obtained from clinical records of 3,449 Vietnamese HIV/AIDS patients aged 18 years or older who initiated ART between 1 January 2005 and 31 December 2009. Mantel-Haenszel chi-square test, log rank test were conducted to examine the trends of baseline characteristics, six month mortality and LTFU. Cox proportional hazards regression models were performed to compute hazard ratio (HR) and 95% Confidence Interval (CI).
Though there was a declining trend, the incidence of six month mortality and LTFU remained as high as 6% and 15%, respectively. Characteristics associated with six month mortality were gender (HR females versus males 0.54, 95%CI: 0.34-0.85), years of initiation (HR 2009 versus 2005 0.54, 95%CI: 0.41-0.80), low baseline CD4 (HR 350-500 cells/mm(3) versus <50 cells/mm(3) 0.26, 95%CI: 0.18-0.52), low baseline BMI (one unit increase: HR 0.96, 95%CI: 0.94-0.97), co-infection with TB (HR 1.61, 95%CI: 1.46-1.95), history of injecting drugs (HR 1.58, 95%CI: 1.31-1.78). Characteristics associated with LTFU were younger age (one year younger: HR 0.97, 95%CI: 0.95-0.98), males (HR females versus males 0.82, 95%CI: 0.63-0.95), and poor adherence (HR 0.55, 95%CI: 0.13-0.87).
To reduce early mortality, special attention is required to ensure timely access to ART services, particularly for patients at higher risk. Patients at risk for LTFU after ART initiation should be targeted through enhancing treatment counselling and improving patient tracing system at ART clinics.
本研究旨在描述 2005-2009 年期间越南 13 家门诊诊所的六个月死亡率和失访(LTFU)的趋势和决定因素。
数据来自 2005 年 1 月 1 日至 2009 年 12 月 31 日期间开始接受抗逆转录病毒治疗的 3449 名 18 岁及以上越南艾滋病毒/艾滋病患者的临床记录。采用 Mantel-Haenszel χ²检验和对数秩检验来检验基线特征、六个月死亡率和 LTFU 的趋势。采用 Cox 比例风险回归模型计算风险比(HR)和 95%置信区间(CI)。
尽管有下降趋势,但六个月死亡率和 LTFU 的发生率仍高达 6%和 15%。与六个月死亡率相关的特征包括性别(女性与男性的 HR 为 0.54,95%CI:0.34-0.85)、起始年限(2009 年与 2005 年的 HR 为 0.54,95%CI:0.41-0.80)、低基线 CD4(350-500 个细胞/mm³与<50 个细胞/mm³的 HR 为 0.26,95%CI:0.18-0.52)、低基线 BMI(每增加一个单位:HR 为 0.96,95%CI:0.94-0.97)、合并结核感染(HR 为 1.61,95%CI:1.46-1.95)、有吸毒史(HR 为 1.58,95%CI:1.31-1.78)。与 LTFU 相关的特征包括年龄较小(每年年轻一岁:HR 为 0.97,95%CI:0.95-0.98)、男性(女性与男性的 HR 为 0.82,95%CI:0.63-0.95)和药物依从性差(HR 为 0.55,95%CI:0.13-0.87)。
为降低早期死亡率,需要特别关注确保及时获得抗逆转录病毒治疗服务,特别是对于高危患者。对于开始抗逆转录病毒治疗后有失访风险的患者,应通过加强治疗咨询和改善抗逆转录病毒治疗诊所的患者追踪系统来加以解决。